ARFIP2

Arfaptin-2 · P53365 · ARFIP2 on Sugi Atlas →

0 patent compounds predicted against ARFIP2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ARFIP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Evaluation of the Predictive Effect of Inflammatory Markers in MI Patients nanUNKNOWN
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Autophagy Bladder Cancer nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers nanCOMPLETED
Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study nanUNKNOWN
Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning nanUNKNOWN
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Immune Cell Response to Stimuli nanRECRUITING
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Biomarkers in Patients With Rhabdomyosarcoma nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ARFIP2 binder may also engage these)

ProteinNameSimilarity
Q3ZCL5 1.000 Q3ZCL5 →
Q8K221 1.000 Q8K221 →
Q6AY65 1.000 Q6AY65 →
G5E8V9 0.996 G5E8V9 →
Q9JHU5 0.993 Q9JHU5 →
P53367 0.983 P53367 →
Q6PCS4 0.977 Q6PCS4 →
Q63054 0.974 Q63054 →
Q7YQL6 0.974 Q7YQL6 →
Q99J31 0.974 Q99J31 →
Q8VWF1 0.974 Q8VWF1 →
O60890 0.973 O60890 →
Q6ZM89 0.973 Q6ZM89 →
Q7YQL5 0.972 Q7YQL5 →
P0CAX5 0.972 P0CAX5 →
Q6ZT62 0.972 Q6ZT62 →
Q28E02 0.972 Q28E02 →
Q6P9S0 0.972 Q6P9S0 →
Q4V7P7 0.971 Q4V7P7 →
Q5R4C2 0.971 Q5R4C2 →
Q2HWF0 0.971 Q2HWF0 →
Q6DCZ7 0.970 Q6DCZ7 →
Q5T0N5 0.970 Q5T0N5 →
Q17R89 0.970 Q17R89 →
A6NI28 0.969 A6NI28 →
BCR Breakpoint cluster region protein 0.969 landscape →
Q566W7 0.969 Q566W7 →
Q6GNV5 0.968 Q6GNV5 →
A1A4L0 0.968 A1A4L0 →
F1LQX4 0.968 F1LQX4 →